About Us

With more than 20 years of academic project-leading experience, Marie contributes with extensive knowledge about molecular drivers for cancer development (1,2), project-leading skills, and an innovative mindset. Marie co-founded Pioneer Research to develop and commercialize a highly versatile proprietary miPCancer Discovery and Development Platform optimized for previously “undruggable” targets utilized in the company’s first lead development program (PR-2304)

After graduating from the University Utah, US, Emily was recruited to work in the US’s competitive pharmaceutical Industry, igniting her interest in developing an improved knowledge-based treatment for tomorrow’s patients. She returned to Norway for her master’s degree in transcription factor regulation in cancer at the Medical Faculty at the University of Oslo (3,4). She co-founded Pioneer Research to contribute innovative solutions and strategies to develop the PR-2304 lead program and commercialize the miPCancer Platform.

Saranya is an experienced protein biochemist with a PhD in structural biology from the Department of Pharmacy at the University of Oslo. She has more than 5 years of research experience at the Medical Faculty of the University of Oslo following her PhD, working in a research group focusing on gene regulation using a structural biology approach. Her in-depth knowledge of structural biology and peptide characterization will contribute to advancing Pioneer Research’s development of miPs for therapeutic use.